logo
Menu
Innovation Observatory > Reports > Drugs > Dabigatran Etexilate (Pradaxa) for Secondary Stroke Prevention in Patients with Embolic Stroke of Undetermined Source – First Line

< Back

Dabigatran Etexilate (Pradaxa) for Secondary Stroke Prevention in Patients with Embolic Stroke of Undetermined Source – First Line

Drugs

Neurology and Neurosurgery

December 2017


Dabigatran etexilate is an oral drug that acts by preventing clots from forming and blocking blood vessels. It is already available for the treatment and prevention of stroke and other types of blood clots affecting blood vessels and organs in the body. By preventing clots from forming, it can prevent future embolic strokes. This could be particularly useful for people who have just experienced an embolic stroke who are at high risk of having another subsequent stroke.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Download Full article



 

Connect to the Innovation Observatory

Twitter

Load More Related Posts
Get Alerts